Impact of the occurrence of new lesions on the survival of patients who undergo chemotherapy for metastatic colorectal cancer

In clinical practice, the efficacy of chemotherapy for metastatic colorectal cancer (mCRC) is typically evaluated according to the Response Evaluation Criteria in Solid Tumours (RECIST) criteria, and an appropriate treatment plan is determined. In the case of progressive disease (PD), the components...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Mol Clin Oncol
Egile Nagusiak: Shibutani, Masatsune, Maeda, Kiyoshi, Nagahara, Hisashi, Fukuoka, Tatsunari, Matsutani, Shinji, Kashiwagi, Shinichiro, Hirakawa, Kosei, Ohira, Masaichi
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: D.A. Spandidos 2019
Gaiak:
Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6327212/
https://ncbi.nlm.nih.gov/pubmed/30680209
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2018.1778
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak